The Transcatheter Heart Valve Replacement Repair Market is estimated to witness stupendous growth in the years to come. AI is already into the disruption mode regarding the healthcare vertical. Machine learning is used for displaying the relevant info about health in the mobile app. The application of AI in healthcare is better known as “Augmented Intelligence”. This would be the running trend in the healthcare vertical in the upcoming period.
According to the latest market report published by Persistence Market Research titled ‘Global Transcatheter Heart Valve Replacement & Repair Market: Global Industry Analysis and Forecast, 2016 – 2026, the global transcatheter heart valve replacement & repair market is projected to expand at a CAGR of 13.9% during the forecast period (2016–2026).
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/11167
Transcatheter heart valve replacement is a relatively non-invasive procedure to repair the damaged heart valves with bioprosthetic valves for treatment of valvular heart disease namely aortic stenosis and mitral regurgitation among geriatric population. It is an alternative approach to conventional open heart surgery, especially for extremely high risk patients. Transcatheter heart valve replacement & repair market was valued at US$ 1,605.5 Mn in 2015 and the revenue is expected to increase to US$ 6,701.5 Mn by 2026 at a CAGR of 13.9% over the forecast period.
- Edwards LifeSciences Corporation
- Medtronic, Inc.
- Boston Scientific Corporation
- Abbott Laboratories
- St. Jude Medical, Inc.
- JenaValve Technology
- Braile Biomedica
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/11167
The report offers market forecast and analysis on global transcatheter heart valve replacement & repair market, segmenting the market on the basis of product type, surgical approach, end user and region. The report segments the global transcatheter heart valve replacement & repair market into seven key regions namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East and Africa (MEA). According to PMR’s regional analysis, North America (U.S. and Canada) is the most lucrative market for transcatheter heart valve replacement & repair. This market in the region is expected to account for largest share throughout the forecast period, albeit exhibiting a slow growth rate. Asia Pacific is expected to be the fastest growing market for transcatheter heart valve replacement & repair, owing to increasing prevalence rate of cardiovascular diseases such as valvular heart disease and rising population in the region. Asia Pacific is estimated to account for 6.2 % revenue share by end of 2016 in the transcatheter heart valve replacement & repair market.
On the basis of product type, PMR has segmented the transcatheter heart valve replacement & repair market into TAVR (Transcatheter Aortic Valve replacement) and TMVR (Transcatheter Mitral Valve Repair). TAVR segment is expected to dominate the market through the forecast period and is anticipated to be the most lucrative segment. Due to high adoption rate of TAVR devices across the globe, this segment is expected to witness high incremental opportunity between 2016 and 2026.
On the basis of surgical approach, the transcatheter heart valve replacement & repair market has been segmented into transfemoral approach, transapical approach and transaortic approach. Transfemoral approach segment is expected to dominate the market through the forecast period and is anticipated to be the most lucrative segment. Due to high adoption rate of transfemoral approach by cardiologists, this segment is expected to witness high incremental opportunity.
On the basis of end user, the transcatheter heart valve replacement & repair market has been segmented into hospitals, ambulatory surgical centres and cardiac catheterization laboratories. As per PMR analysis, among end users, the hospitals segment accounted for highest revenue share in 2015 and is expected to witness fastest growth over the forecast period. This is mainly attributed to increasing patient population seeking effective and efficient treatment with shorter recovery time. Cardiac catheterization laboratory segment is also expected to exhibit significant growth during the forecast period, as it provides better treatment facilities and ease of access.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/11167
The transcatheter heart valve replacement market is segmented as follows:
By Product Type
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcatheter Mitral Valve Repair (TMVR)
By Surgical Approach
- Transfemoral Approach
- Transapical Approach
- Transaortic Approach
By End User
- Ambulatory Surgical Centres
- Cardiac Catheterization Laboratory
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific excluding Japan
- Middle East & Africa
About Us: Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Sales – email@example.com
Website – https://www.persistencemarketresearch.com